Cross-Trial Comparisons in the Oncology Arena: When Is This Justified?

Publisher： Karger

E-ISSN： 1423-0232|80|3-4|151-152

ISSN： 0030-2414

Source： Oncology, Vol.80, Iss.3-4, 2011-06, pp. : 151-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Comparative efficacy of biological treatments for moderate‐to‐severe psoriasis: a network meta‐analysis adjusting for cross‐trial differences in reference arm response

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 2, 2015-02 ,pp. : 504-512

John Wiley & Sons Inc

Access to resources Recommend Favorite

Arena

By  

CLINICAL ORAL IMPLANTS RESEARCH, Vol. 27, Iss. S13, 2016-09 ,pp. : 1-1

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial

By Derosa Giuseppe   Salvadeo Sibilla A. T.   D’Angelo Angela   Ferrari Ilaria   Mereu Roberto   Palumbo Ilaria   Maffioli Pamela   Randazzo Sabrina   Cicero Arrigo F. G.  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 607-615

Informa Healthcare

Access to resources Recommend Favorite

A scientific nutrition strategy improves time trial performance by ≍6% when compared with a self-chosen nutrition strategy in trained cyclists: a randomized cross-over study

By Hottenrott Kuno  

Applied Physiology, Nutrition, and Metabolism, Vol. 37, Iss. 4, 2012-08 ,pp. : 637-645

NRC Research Press

Access to resources Recommend Favorite

Modeling between-trial variance structure in mixed treatment comparisons

By Lu Guobing   Ades Ae  

Biostatistics, Vol. 10, Iss. 4, 2009-10 ,pp. : 792-805

Oxford University Press

Access to resources Recommend Favorite